Public Release: 20-Oct-2015
NIH/National Institute of Allergy and Infectious Diseases
Drug-resistant forms of Plasmodium falciparum, the deadliest species among malaria parasites, are able to infect the type of mosquito that is the main transmitter of malaria in Africa, according to findings from scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and global partners. The discovery suggests Africa–where malaria will cause an estimated 400,000 deaths in 2015–is more at risk for drug-resistant malaria infections than previously thought, which could further compromise efforts to prevent and eliminate the disease.
P. falciparum parasites resistant to artemisinin, the main drug used to treat malaria, have been rapidly spreading in parts of Southeast Asia, making it difficult to treat and control infections there. Malaria experts are concerned artemisinin-resistant parasites could spread to Africa, but until now, there were no scientific indications to suggest that these parasites could infect Anopheles coluzzii (formerly Anopheles gambiae M form) mosquitoes, the species largely responsible for transmitting malaria in Africa. To investigate the transmission potential of these parasites, scientists infected various mosquito species from Southeast Asia and Africa with artemisinin-resistant parasites from Cambodia in a laboratory setting. They discovered the parasites easily infected Southeast Asian mosquito carriers Anopheles dirus and Anopheles minimus, as well as Anopheles coluzzii. The scientists also discovered a shared genetic background among artemisinin-resistant parasites that may enable them to infect diverse mosquito species by evading their immune systems.
The ability of artemisinin-resistant parasites to infect diverse Anopheles species may help explain the spread of resistance that has occurred in Southeast Asia in recent years and poses challenges to preventing the spread of resistant parasites to Africa, the authors write. The researchers plan to investigate other potential genetic determinants of parasite infection of mosquitoes and further examine which Anopheles species from Cambodia are naturally transmitting artemisinin-resistant parasites in the wild.
St. Laurent B et al. Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa. Nature Communications DOI: 10.1038/ncomms9614 (2015).
Rick M. Fairhurst, M.D., Ph.D., chief, Malaria Pathogenesis and Human Immunity Unit in NIAID’s Laboratory of Malaria and Vector Research, is available to comment on this research.
To schedule interviews, please contact Jennifer Routh, (301) 402-1663, email@example.com. NIAID conducts and supports research–at NIH, throughout the United States, and worldwide–to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH…Turning Discovery Into Health®
Categories: . Enhanced Disease Transmission